Heart Attack

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End CashTonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the…

5 months ago
Counterpart Health Signs Multi-Year Agreement with Southern Illinois HealthcareCounterpart Health Signs Multi-Year Agreement with Southern Illinois Healthcare

Counterpart Health Signs Multi-Year Agreement with Southern Illinois Healthcare

WILMINGTON, Del., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced a…

5 months ago
Celebrating the Winners of the Inaugural Sony Women in Technology Award with NatureCelebrating the Winners of the Inaugural Sony Women in Technology Award with Nature

Celebrating the Winners of the Inaugural Sony Women in Technology Award with Nature

NEW YORK and LONDON and BERLIN and TOKYO, Feb. 4, 2025 /PRNewswire/ -- Sony Group Corporation (Sony) and Nature are proud…

5 months ago
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock SplitTonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated…

5 months ago
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock SplitTonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated…

5 months ago
23andMe Launches New Genetic Report on Osteoporosis23andMe Launches New Genetic Report on Osteoporosis

23andMe Launches New Genetic Report on Osteoporosis

Provides 23andMe+ Premium members with insight into their likelihood of developing osteoporosis based on thousands of genetic variantsSUNNYVALE, Calif., Jan.…

5 months ago
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought LeaderAxsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader

Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader

NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…

5 months ago
HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UKHealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)…

5 months ago